Leo Pharma has appointed Waggener Edstrom to help drive awareness of its anticoagulant Innohep (tinzaparin) in the German market.
The Munich offices of the communications agency won the account following a competitive pitch process, with the pharma company citing a compelling campaign proposal as a determining factor.
“We are very proud to win an account with a prestigious company like Leo Pharma,” said Manuel Hüttl, VP and general manager of Waggener Edstrom Worldwide, Germany, Austria and Switzerland.
“We are looking forward to supporting the Leo Pharma team with the development and execution of innovative, creative and bold strategies.”
Since the acquisition of healthcare comms agency Patzer PR in 2012, Waggener Edstrom has been adding names to its list of pharma clients, which includes Astellas, 3M Espe, Berlin Chemie, Medice, AOK Baden-Württemberg and now Leo Pharma.